Sangamo Therapeutics Inc (SGMO)

12:06 PM

Sangamo Therapeutics, Inc. Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy - MarketScreener

12:06 PM

10:02 AM

Sangamo Therapeutics (SGMO) Surges on FDA Fast Track Designation for ST-503 - GuruFocus

10:02 AM

09:16 AM

Sangamo rises as FDA grants Fast Track status to neuropathic pain asset - Seeking Alpha

09:16 AM

09:04 AM

Sangamo (SGMO) Gains FDA Fast Track for Chronic Pain Treatment - GuruFocus

09:04 AM

08:30 AM

Sangamo Therapeutics secures FDA fast track for ST-503 - Traders Union

08:30 AM

08:16 AM

Sangamo Therapeutics receives U.S. FDA fast track designation for ST-503 - MarketScreener

08:16 AM

08:10 AM

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy - The Manila Times

08:10 AM

08:05 AM

Sangamo Therapeutics (Nasdaq: SGMO) gets FDA Fast Track for ST-503 in small fiber neuropathy - Stock Titan

08:05 AM

04:27 AM

How Sangamo Therapeutics Inc. (GBY) stock performs in volatility spikesIndex Update & Proven Capital Preservation Methods - Newser

04:27 AM

01:28 AM

Can Sangamo Therapeutics Inc. (GBY) stock reach $200 price targetTrade Ideas & AI Powered Market Entry Ideas - Newser

01:28 AM

12:03 PM

Is Sangamo Therapeutics Inc. (GBY) stock a top hedge fund pick2025 Technical Patterns & High Yield Stock Recommendations - Newser

12:03 PM

Nov 29, 2025

Earnings Report: Is Sangamo Therapeutics Inc. stock attractive for retirement portfolios2025 Top Gainers & Capital Efficient Trading Techniques - BỘ NỘI VỤ

Nov 29, 2025

Nov 28, 2025

Sangamo Therapeutics Q3 2025 Earnings Preview - MSN

Nov 28, 2025

Nov 28, 2025

Sangamo Therapeutics, Inc. (GBY.F) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 28, 2025

Nov 28, 2025

How Recent Developments Are Rewriting the Story for Sangamo Therapeutics - Yahoo Finance

Nov 28, 2025

Nov 26, 2025

[Form 4] SANGAMO THERAPEUTICS, INC Insider Trading Activity - Stock Titan

Nov 26, 2025

Nov 26, 2025

What drives Sangamo Therapeutics Inc. (GBY) stock priceCandlestick Trading Patterns & High Return Investment Ideas - earlytimes.in

Nov 26, 2025

Nov 25, 2025

Sangamo rises as FDA accepts rolling submission request for gene therapy - MSN

Nov 25, 2025

Nov 23, 2025

Revenues Working Against Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Share Price Following 33% Dive - simplywall.st

Nov 23, 2025

Nov 22, 2025

What analysts say about Sangamo Therapeutics Inc GBY stockDividend Yield Trends & The Smart Money Is Buying These Picks - earlytimes.in

Nov 22, 2025

Nov 21, 2025

Sangamo Therapeutics, Inc. (SGMO) Stock: Soars 9.95% on FDA Milestone for Gene Therapy - parameter.io

Nov 21, 2025

Nov 21, 2025

With cash running low, East Bay biotech Sangamo bets on FDA submission strategySan Francisco Business Times - The Business Journals

Nov 21, 2025

Nov 21, 2025

Sangamo Therapeutics Gets US FDA Approval to Begin Rolling BLA Submission for Fabry Gene Therapy - MarketScreener

Nov 21, 2025

Nov 21, 2025

Sangamo Therapeutics (SGMO) Advances Fabry Disease Therapy with FDA Rolling Submission - GuruFocus

Nov 21, 2025

Nov 21, 2025

Sangamo (SGMO) Advances Gene Therapy for Fabry Disease with FDA Approval Process - GuruFocus

Nov 21, 2025

Nov 21, 2025

FDA accepts Sangamo’s rolling BLA submission for Fabry disease gene therapy - Investing.com Canada

Nov 21, 2025

Nov 21, 2025

Sangamo Therapeutics announces FDA acceptance of BLA rolling submission request - MarketScreener

Nov 21, 2025

Nov 21, 2025

Sangamo Therapeutics Announces FDA Acceptance of Rolling Submission for Gene Therapy ST-920 for Fabry Disease Treatment - Quiver Quantitative

Nov 21, 2025

Nov 21, 2025

Sangamo stock climbs after FDA accepts BLA rolling submission request By Investing.com - Investing.com Canada

Nov 21, 2025

Nov 21, 2025

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease - The Manila Times

Nov 21, 2025

Nov 21, 2025

Sangamo (Nasdaq: SGMO) rolling ST-920 Fabry BLA accepted by FDA for accelerated review - Stock Titan

Nov 21, 2025

Nov 21, 2025

Will Sangamo Therapeutics Inc. (GBY) stock rise with strong economyWeekly Trend Report & Verified Technical Trade Signals - newser.com

Nov 21, 2025

Nov 21, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Nov 21, 2025

Nov 20, 2025

Will Sangamo Therapeutics Inc. (GBY) stock gain from green policiesQuarterly Investment Review & Safe Entry Trade Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Sangamo Therapeutics (SGMO) Price Target Decreased by 20.73% to 3.32 - MSN

Nov 19, 2025

Nov 19, 2025

Real time pattern detection on Sangamo Therapeutics Inc. stockJuly 2025 Summary & Expert Approved Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

How buybacks impact Sangamo Therapeutics Inc. stock value2025 Retail Activity & Real-Time Volume Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

How hedge fund analytics apply to Sangamo Therapeutics Inc. stockMarket Performance Recap & Consistent Profit Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Sangamo Therapeutics Inc. stock chart pattern explainedTrend Reversal & Reliable Trade Execution Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Tick level data insight on Sangamo Therapeutics Inc. volatilityJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Why analysts recommend Sangamo Therapeutics Inc. (GBY) stock2025 Year in Review & Fast Entry and Exit Trade Plans - newser.com

Nov 19, 2025